Details

NameSymbolSector
HESTER BIOSCIENCES LTDHESTERBIOPharmaceuticals
Open
2196
High
2247
Low
2185.1
Close
2236.5
Volume
2783
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

0.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Hester Biosciences is  
Normal
Estimated Stoploss of Hester Biosciences is ₹  
2185.1
Hester Biosciences has a  
Bullishℹ
 pattern. 
Formation of  
Normal
 candle pattern indicates the trend direction of Hester Biosciences is  
Unpredictableℹ
. 

Trend

Hester Biosciences is in  
Sideways trendℹ
. 
Price of Hester Biosciences is  
Downℹ
 by  

1

%. 
Target
Buy @ 

2007.57

Sell @ 

2587.03

Current @ 

2236.5

Volume

The trade volumes of Hester Biosciences have become  
Deficientℹ
The volume trend for Hester Biosciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Hester Biosciences is  

Down

 by  

87.75

% 

Valuation

The current market price of Hester Biosciences is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 653cr and total assets worth ₹ 653cr, the balance sheet of Hester Biosciences is:  
Balancedℹ
. 
Cashflow
Hester Biosciences has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 6cr

. It is  
Downℹ
 by  

0

%. 
47.76% i.e. ₹ 64cr earned in operatingℹ
14.18% i.e. ₹ 19cr spent in investingℹ
38.06% i.e. ₹ 51cr spent in financingℹ
0% in otherℹ
Hester Biosciences has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 
50% i.e. ₹ 48cr earned in operatingℹ
22.92% i.e. ₹ 22cr spent in investingℹ
27.08% i.e. ₹ 26cr spent in financingℹ
0% in otherℹ
Income
The income of Hester Biosciences is  

₹ 80cr

 and  

Profit

 is :  

₹ 12cr

Hester Biosciences Profit is down by:  

25

% and Income is Down by:  

6.98

% 
The income of Hester Biosciences is  

₹ 86cr

 and  

Profit

 is :  

₹ 16cr

Hester Biosciences Profit is up by:  

1600

% and Income is Up by:  

16.22

% 
The income of Hester Biosciences is  

₹ 74cr

 and  

Loss

 is :  

₹ 0cr

Hester Biosciences Losses increased by:  

100

% and Income is Up by:  

4.23

% 
By using this site you agree to the use of cookies to deliver a better site experience.